Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.
Mas S, Gassó P, Torra M, Bioque M, Lobo A, González-Pinto A, Olmeda MS, Corripio I, Vieta E, Castro-Fornieles J, Rodriguez-Jimenez R, Bobes J, Usall J, Llerena A, Saiz-Ruiz J, Bernardo M, Lafuente A, PEPs Group. Mas S, et al. Eur Neuropsychopharmacol. 2017 Jul;27(7):647-656. doi: 10.1016/j.euroneuro.2017.03.012. Epub 2017 Apr 5. Eur Neuropsychopharmacol. 2017. PMID: 28389049
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.
Bioque M, Llerena A, Cabrera B, Mezquida G, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Aguilar EJ, Bulbena A, Castro-Fornieles J, Vieta E, Lafuente A, Mas S, Parellada M, Saiz-Ruiz J, Cuesta MJ, Bernardo M; PEPs GROUP. Bioque M, et al. Int J Neuropsychopharmacol. 2016 Mar 31;19(4):pyv121. doi: 10.1093/ijnp/pyv121. Print 2016 Apr. Int J Neuropsychopharmacol. 2016. PMID: 26506856 Free PMC article.
Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis.
Bioque M, García-Portilla MAP, García-Rizo C, Cabrera B, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Vieta E, Castro-Fornieles J, Bobes J, Gutiérrez-Fraile M, Rodriguez-Jimenez R, Mezquida G, Llerena A, Saiz-Ruiz J, Bernardo M; PEPs GROUP. Bioque M, et al. Schizophr Res. 2018 Mar;193:188-196. doi: 10.1016/j.schres.2017.06.032. Epub 2017 Jun 26. Schizophr Res. 2018. PMID: 28663026
Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis.
Gassó P, Mas S, Bioque M, Cabrera B, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Vieta E, Castro-Fornieles J, Sarró S, Mané A, Sanjuan J, Llerena A, Lafuente A, Saiz-Ruiz J, Bernardo M; PEPs Group. Gassó P, et al. J Psychopharmacol. 2018 Jun;32(6):702-710. doi: 10.1177/0269881118773026. Epub 2018 May 16. J Psychopharmacol. 2018. PMID: 29767567
Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year period.
Gassó P, Arnaiz JA, Mas S, Lafuente A, Bioque M, Cuesta MJ, Díaz-Caneja CM, García C, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Castro-Fornieles J, Mané A, Rodríguez N, Boloc D, Saiz-Ruiz J, Bernardo M; PEPs Group. Gassó P, et al. J Psychopharmacol. 2020 May;34(5):514-523. doi: 10.1177/0269881120903462. Epub 2020 Feb 3. J Psychopharmacol. 2020. PMID: 32009515
Examining Gene-Environment Interactions Using Aggregate Scores in a First-Episode Psychosis Cohort.
Mas S, Boloc D, Rodríguez N, Mezquida G, Amoretti S, Cuesta MJ, González-Peñas J, García-Alcón A, Lobo A, González-Pinto A, Corripio I, Vieta E, Castro-Fornieles J, Mané A, Saiz-Ruiz J, Gassó P, Bioque M, Bernardo M; PEPs Group. Mas S, et al. Schizophr Bull. 2020 Jul 8;46(4):1019-1025. doi: 10.1093/schbul/sbaa012. Schizophr Bull. 2020. PMID: 32083289 Free PMC article.
Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.
Mas S, Gassó P, Lafuente A, Bioque M, Lobo A, Gonzàlez-Pinto A, Olmeda MS, Corripio I, Llerena A, Cabrera B, Saiz-Ruiz J, Bernardo M; PEPs GROUP. Mas S, et al. Pharmacogenomics J. 2016 Oct;16(5):439-45. doi: 10.1038/tpj.2016.44. Epub 2016 Jun 7. Pharmacogenomics J. 2016. PMID: 27272046
Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort.
Mas S, Gassó P, Rodríguez N, Cabrera B, Mezquida G, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Castro-Fornieles J, Bobes J, Usall J, Saiz-Ruiz J, Contreras F, Parellada E, Bernardo M; PEPs group. Mas S, et al. Acta Psychiatr Scand. 2020 Jun;141(6):541-552. doi: 10.1111/acps.13131. Epub 2019 Dec 5. Acta Psychiatr Scand. 2020. PMID: 31746462
Antipsychotic switching in bipolar disorders: a systematic review.
Grande I, Bernardo M, Bobes J, Saiz-Ruiz J, Álamo C, Vieta E. Grande I, et al. Int J Neuropsychopharmacol. 2014 Mar;17(3):497-507. doi: 10.1017/S1461145713001168. Epub 2013 Oct 21. Int J Neuropsychopharmacol. 2014. PMID: 24139622 Free article. Review.
227 results